TBX4 Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-85889
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Format
BSA Free
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the middle region of human TBX4. Peptide sequence: LRVARLQSKEYPVISKSIMRQRLISPQLSATPDVGPLLGTHQALQHYQHE The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for TBX4 Antibody - BSA Free
Western Blot: TBX4 Antibody [NBP2-85889]
Western Blot: TBX4 Antibody [NBP2-85889] - WB Suggested Anti-TBX4 Antibody Titration: 0.2-1 ug/ml. Positive Control: HepG2 cell lysateWestern Blot: TBX4 Antibody [NBP2-85889]
Western Blot: TBX4 Antibody [NBP2-85889] - Host: Rabbit. Target: TBX4. Positive control (+): Human lung (LU). Negative control (-): MCF7 (N10). Antibody concentration: 1ug/mlWestern Blot: TBX4 Antibody [NBP2-85889]
Western Blot: TBX4 Antibody [NBP2-85889] - Host: Rabbit. Target Name: TBX4. Sample Tissue: Human 293T Whole Cell. Antibody Dilution: 2ug/mlApplications for TBX4 Antibody - BSA Free
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Format
BSA Free
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: TBX4
Alternate Names
SPS, T-box 4, T-box protein 4, T-box transcription factor TBX4
Gene Symbol
TBX4
Additional TBX4 Products
Product Specific Notices for TBX4 Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...